UCSF Magazine |
Trip therapy
Could psychedelics become mainstream medicines?
UC Riverside |
Is ChatGPT a threat to education?
Experts share thoughts on the AI-powered language model that understands and responds to natural language.
UC San Diego |
A new phase for clinical trials
Emerging technologies, social imperatives and the next pandemic are changing how clinical trials look and work.
UC San Diego |
In the wake of a wildfire, changes in cognition and brain function linger
Persons exposed to the deadly Camp Fire in 2018 displayed evidence of what is known as “climate trauma.”
UC Riverside |
Gas stoves: Why did they become the pariah du jour?
With the chorus for banning gas stoves growing, a methane expert explains the science behind the rancor.
UC San Francisco |
Ward 86 at 40: Shaping HIV care around the world
The revolutionary Ward 86 turns 40 this year and is still developing new ways to care for people living with HIV.
UC Santa Cruz via The Conversation |
How California could save up its rain to ease future droughts — instead of watching epic atmospheric river rainfall drain into the Pacific
Urban infrastructure was designed to take stormwater out to the ocean quickly. Now, California needs that precious water.
UC San Diego |
UV-emitting nail polish dryers damage DNA and cause cell mutations
Researchers found devices used to cure gel manicures lead to cell death and cancer-causing mutations in human cells.
UC Berkeley |
Among less-educated young workers, women and Black men are paid far less
Women of all races, as well as Black men, who have not attended college are paid dramatically less than Asian American and white men at similar education levels.
UC Davis |
UC Davis researchers study telemedicine for cats
Video veterinary appointments could increase access to medical care.
UC Irvine |
How UC Irvine saved the ozone layer
Research by F. Sherwood Rowland and Mario Molina is at the heart of a recent U.N. report that the ozone hole is closing.
UC San Francisco |
30 years on, are we winning the fight against Alzheimer’s?
Lecanemab, Donanemab, and other drug-free strategies have emerged as weapons against dementia.